XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2020   94,483,136      
Balance at beginning of period at Dec. 31, 2020 $ 2,746,649 $ 931 $ 2,354,871 $ 330,555 $ 60,292
Increase (Decrease) in Stockholders' Equity          
Net income 164,970     164,970  
Other comprehensive (loss) income (33,768)       (33,768)
Repurchase and retirement of common stock (in shares)   (199,674)      
Repurchase and retirement of common stock (6,897) $ (2) (4,977) (1,918)  
Cash dividends declared (59,521)     (59,521)  
Dividend equivalents declared 0   234 (234)  
Share-based compensation expense 6,562   6,562    
Issuance of restricted stock, net (in shares)   435,957      
Issuance of restricted stock, net 0 $ 2 (2)    
Restricted stock surrendered and canceled (in shares)   (110,027)      
Restricted stock surrendered and canceled (5,308)   (5,308)    
Exercise of stock options (in shares)   47,183      
Exercise of stock options 732   732    
Balance at end of period (in shares) at Jun. 30, 2021   94,656,575      
Balance at end of period at Jun. 30, 2021 2,813,419 $ 931 2,352,112 433,852 26,524
Balance at beginning of period (in shares) at Mar. 31, 2021   94,644,415      
Balance at beginning of period at Mar. 31, 2021 2,703,098 $ 931 2,348,445 368,911 (15,189)
Increase (Decrease) in Stockholders' Equity          
Net income 96,302     96,302  
Other comprehensive (loss) income 41,713       41,713
Cash dividends declared (31,234)     (31,234)  
Dividend equivalents declared 0   127 (127)  
Share-based compensation expense 3,457   3,457    
Issuance of restricted stock, net (in shares)   16,200      
Issuance of restricted stock, net 0        
Restricted stock surrendered and canceled (in shares)   (9,477)      
Restricted stock surrendered and canceled (29)   (29)    
Exercise of stock options (in shares)   5,437      
Exercise of stock options 112   112    
Balance at end of period (in shares) at Jun. 30, 2021   94,656,575      
Balance at end of period at Jun. 30, 2021 $ 2,813,419 $ 931 2,352,112 433,852 26,524
Balance at beginning of period (in shares) at Dec. 31, 2021 94,389,543 94,389,543      
Balance at beginning of period at Dec. 31, 2021 $ 2,886,311 $ 929 2,351,294 541,950 (7,862)
Increase (Decrease) in Stockholders' Equity          
Net income 66,904        
Balance at end of period (in shares) at Mar. 31, 2022   94,945,849      
Balance at end of period at Mar. 31, 2022 $ 2,783,018 $ 933 2,348,727 577,591 (144,233)
Balance at beginning of period (in shares) at Dec. 31, 2021 94,389,543 94,389,543      
Balance at beginning of period at Dec. 31, 2021 $ 2,886,311 $ 929 2,351,294 541,950 (7,862)
Increase (Decrease) in Stockholders' Equity          
Net income 136,707     136,707  
Other comprehensive (loss) income (207,156)       (207,156)
Cash dividends declared (62,469)     (62,469)  
Dividend equivalents declared 0   245 (245)  
Share-based compensation expense 9,835   9,835    
Issuance of restricted stock, net (in shares)   761,777      
Issuance of restricted stock, net 0 $ 4 (4)    
Restricted stock surrendered and canceled (in shares)   (212,503)      
Restricted stock surrendered and canceled (8,674)   (8,674)    
Exercise of stock options (in shares)   37,788      
Exercise of stock options $ 665   665    
Balance at end of period (in shares) at Jun. 30, 2022 94,976,605 94,976,605      
Balance at end of period at Jun. 30, 2022 $ 2,755,219 $ 933 2,353,361 615,943 (215,018)
Balance at beginning of period (in shares) at Mar. 31, 2022   94,945,849      
Balance at beginning of period at Mar. 31, 2022 2,783,018 $ 933 2,348,727 577,591 (144,233)
Increase (Decrease) in Stockholders' Equity          
Net income 69,803     69,803  
Other comprehensive (loss) income (70,785)       (70,785)
Cash dividends declared (31,327)     (31,327)  
Dividend equivalents declared 0   124 (124)  
Share-based compensation expense 4,305   4,305    
Issuance of restricted stock, net (in shares)   46,994      
Issuance of restricted stock, net 0   0    
Restricted stock surrendered and canceled (in shares)   (37,284)      
Restricted stock surrendered and canceled (126)   (126)    
Exercise of stock options (in shares)   21,046      
Exercise of stock options $ 331   331    
Balance at end of period (in shares) at Jun. 30, 2022 94,976,605 94,976,605      
Balance at end of period at Jun. 30, 2022 $ 2,755,219 $ 933 $ 2,353,361 $ 615,943 $ (215,018)